102 related articles for article (PubMed ID: 26038607)
21. Surgical Treatment of Small Bowel Neuroendocrine Tumors.
Farley HA; Pommier RF
Hematol Oncol Clin North Am; 2016 Feb; 30(1):49-61. PubMed ID: 26614368
[TBL] [Abstract][Full Text] [Related]
22. Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors.
Shi C; Gonzalez RS; Zhao Z; Koyama T; Cornish TC; Hande KR; Walker R; Sandler M; Berlin J; Liu EH
Am J Clin Pathol; 2015 Mar; 143(3):398-404. PubMed ID: 25696798
[TBL] [Abstract][Full Text] [Related]
23. [Management of treatment in patients with neuroendocrine neoplasmas of digestive tract].
Kinová S; Kovácová M; Caprnda M; Koren M
Vnitr Lek; 2015 Dec; 61(12 Suppl 5):5S12-20. PubMed ID: 27124967
[TBL] [Abstract][Full Text] [Related]
24. Plasma chromogranin A levels predict survival and tumor response in patients with advanced gastroenteropancreatic neuroendocrine tumors.
Chou WC; Chen JS; Hung YS; Hsu JT; Chen TC; Sun CF; Lu CH; Hwang TL
Anticancer Res; 2014 Oct; 34(10):5661-9. PubMed ID: 25275071
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic value of serum procalcitonin concentrations in primary lung cancers.
Patout M; Salaün M; Brunel V; Bota S; Cauliez B; Thiberville L
Clin Biochem; 2014 Dec; 47(18):263-7. PubMed ID: 25218831
[TBL] [Abstract][Full Text] [Related]
26. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors.
Abrahams NA; Halverson A; Fazio VW; Rybicki LA; Goldblum JR
Dis Colon Rectum; 2002 Nov; 45(11):1496-502. PubMed ID: 12432298
[TBL] [Abstract][Full Text] [Related]
27. A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection.
Modlin IM; Drozdov I; Alaimo D; Callahan S; Teixiera N; Bodei L; Kidd M
Endocr Relat Cancer; 2014 Aug; 21(4):615-28. PubMed ID: 25015994
[TBL] [Abstract][Full Text] [Related]
28. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
Crona J; Gustavsson T; Norlén O; Edfeldt K; Åkerström T; Westin G; Hellman P; Björklund P; Stålberg P
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1428-35. PubMed ID: 25586243
[TBL] [Abstract][Full Text] [Related]
29. Consensus on biomarkers for neuroendocrine tumour disease.
Oberg K; Modlin IM; De Herder W; Pavel M; Klimstra D; Frilling A; Metz DC; Heaney A; Kwekkeboom D; Strosberg J; Meyer T; Moss SF; Washington K; Wolin E; Liu E; Goldenring J
Lancet Oncol; 2015 Sep; 16(9):e435-e446. PubMed ID: 26370353
[TBL] [Abstract][Full Text] [Related]
30. [Clinicopathological features and multivariate analysis of prognostic factors for patients with gastroenteropancreatic neuroendocrine tumors].
Wang X; Song ZF; Yao WX; Pan CC; Xiang MF; Wang H
Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1411-4. PubMed ID: 24025507
[TBL] [Abstract][Full Text] [Related]
31. Circulating tumor cells and miRNAs as prognostic markers in neuroendocrine neoplasms.
Zatelli MC; Grossrubatscher EM; Guadagno E; Sciammarella C; Faggiano A; Colao A
Endocr Relat Cancer; 2017 Jun; 24(6):R223-R237. PubMed ID: 28389504
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of serum C-reactive protein (CRP) and cytokeratin 19 fragments (Cyfra 21-1) but not carcinoembryonic antigen (CEA) in surgically treated patients with non-small cell lung cancer.
Szturmowicz M; Rudziński P; Kacprzak A; Langfort R; Bestry I; Broniarek-Samson B; Orłowski T
Pneumonol Alergol Pol; 2014; 82(5):422-9. PubMed ID: 25133810
[TBL] [Abstract][Full Text] [Related]
33. A nomogram to assess small-intestinal neuroendocrine tumor ('carcinoid') survival.
Modlin IM; Gustafsson BI; Pavel M; Svejda B; Lawrence B; Kidd M
Neuroendocrinology; 2010; 92(3):143-57. PubMed ID: 20733279
[TBL] [Abstract][Full Text] [Related]
34. Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate.
Ezziddin S; Attassi M; Yong-Hing CJ; Ahmadzadehfar H; Willinek W; Grünwald F; Guhlke S; Biersack HJ; Sabet A
J Nucl Med; 2014 Feb; 55(2):183-90. PubMed ID: 24434296
[TBL] [Abstract][Full Text] [Related]
35. [Small bowel tumors: experience at the Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán"].
Sánchez-Ramón A; Cerino-Palomino V; Medina-Franco H
Rev Gastroenterol Mex; 2012; 77(4):181-5. PubMed ID: 23177666
[TBL] [Abstract][Full Text] [Related]
36. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
[TBL] [Abstract][Full Text] [Related]
37. Peritoneal carcinomatosis from small intestinal neuroendocrine tumors: Clinical course and genetic profiling.
Norlén O; Edfeldt K; Akerstrom G; Westin G; Hellman P; Bjorklund P; Stalberg P
Surgery; 2014 Dec; 156(6):1512-21; discussion 1521-2. PubMed ID: 25456945
[TBL] [Abstract][Full Text] [Related]
38. Neuroendocrine neoplasms of the stomach.
Louthan O
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):455-60. PubMed ID: 23817299
[TBL] [Abstract][Full Text] [Related]
39. Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours.
Blažević A; Zandee WT; Franssen GJH; Hofland J; van Velthuysen MF; Hofland LJ; Feelders RA; de Herder WW
Endocr Relat Cancer; 2018 Mar; 25(3):245-254. PubMed ID: 29255095
[TBL] [Abstract][Full Text] [Related]
40. A rapid rise in circulating pancreastatin in response to somatostatin analogue therapy is associated with poor survival in patients with neuroendocrine tumours.
Stronge RL; Turner GB; Johnston BT; McCance DR; McGinty A; Patterson CC; Ardill JE
Ann Clin Biochem; 2008 Nov; 45(Pt 6):560-6. PubMed ID: 18782815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
